Report
Note: Workshop Summaries contain the opinion of the presenters, but do NOT reflect the conclusions of the IOM. Learn more about the differences between Workshop Summaries and Consensus Reports.
Design Considerations for Evaluating the Impact of PEPFAR is the summary of a 2-day workshop on methodological, policy, and practical design considerations for a future evaluation of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) interventions carried out under the President's Emergency Plan for AIDS Relief (PEPFAR), which was convened by the Institute of Medicine (IOM) on April 30 and May 1, 2007. Participants at the workshop included staff of the U.S. Congress; PEPFAR officials and implementers; major multilateral organizations such as The Global Fund to Fight AIDS, Malaria, and Tuberculosis (The Global Fund), the Joint United Nations Programme on HIV/AIDS (UNAIDS), and the World Bank; representatives from international nongovernmental organizations; experienced evaluation experts; and representatives of partner countries, particularly the PEPFAR focus countries. The workshop represented a final element of the work of the congressionally mandated IOM Committee for the Evaluation of PEPFAR Implementation, which published a report of its findings in 2007 evaluating the first 2 years of implementation, but could not address longer term impact evaluation questions.
Other Reports by this Activity
Displaying: 2 of 2 Reports
-
PEPFAR Implementation: Progress and Promise
In 2003 Congress passed the United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act, which established a five-year, $15 billion initiative to help countries around the world respond to their AIDS epidemics. The initiative is generally referred to by the title of the five-year strategy required by the act—PEPFAR, or the President’s Emergency Plan for AIDS Relief.
Released: March 30, 2007
-
Plan for a Short-Term Evaluation of PEPFAR Implementation: Letter Report 1
Concern for the over 40 million people infected with HIV and others at risk of infection or otherwise affected through the impact on their families and communities moved the US Congress on behalf of the American people to pass in May 2003 an unprecedented $15 billion international public health initiative--the US Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act. Congress mandated that the Institute of Medicine review the groundbreaking initiative created by the legislation--the President's Emergency Plan for AIDS Relief (PEPFAR).
Released: October 31, 2005
Previous Meeting for this Activity